Lansoprazole 30 mg versus omeprazole 40 mg in the treatment of reflux oesophagitis grade II, III and IVa (a Dutch multicentre trial)

European Journal of Gastroenterology and Hepatology

Volumn 8, Issue 11, 1996, Pages 1101-1106

  Mulder, Chris J ^a   Dekker, Willem ^b   Gerretsen, Martijn ^c  

^a RIJNSTATE HOSPITAL   (Netherlands)

^b N   (Netherlands)

^c Hoechst Marion Roussel   (Netherlands)

Author keywords

Clinical trial; Endoscopic healing; Lansoprazole; Omeprazole; Reflux oesophagitis

Indexed keywords

LANSOPRAZOLE; OMEPRAZOLE; STOMACH SECRETION INHIBITOR;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ENDOSCOPY; EYE DISEASE; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEALING; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REFLUX ESOPHAGITIS; RESPIRATORY TRACT DISEASE; SKIN DISEASE; SYMPTOM; UROGENITAL TRACT DISEASE;

EID: 0029846260     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199611000-00013     Document Type: Article

References (25)

1. Wienbeck M, Barnert J: Epidemiology of reflux disease and reflux oesophagitis. Scand J Gastroenterol 1989, 24(S156):7-13.
2. Bardhan KD, Hawkey CJ, Long RC, Morgan AG, Wormsley KG, Moules IK, et al.: Lansoprazole versus ranitidine for the treatment of reflux oesophagitis. Aliment Pharmacol Ther 1995, 9:145-151.
3. Umeda N, Miki K, Hoshino E: Lansoprazole versus famotidine in symptomatic reflux oesophagitis: a randomized multicenter study. J Clin Gastroenterol 1995, 20(S1):17-23.
4. Spencer CM, Faulds D: Lansoprazole: a reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders. Drugs 1994, 48:404-430.
5. Klinkenberg EC, Festen HPM, Meuwissen SGM: Pharmacological management of gastro-oesophageal reflux disease. Drugs 1995, 49:695-710.
6. Hatlebakk JG, Berstad A, Carling L, Svedberg LE, Unge P, Ekström P, et al.: Lansoprazole versus omeprazole in short-term treatment of reflux oesophagilis. Scand J Gastroenterol 1993, 28:224-228.
7. Corallo J, Vicari F, Forestier S, Joubert M: Lansoprazole in acute treatment of reflux oesophagitis [abstract]. Gastroenterology 1993, 104:A58.
8. Castell DO, Richter JE, Robison M, Sontag S: Large trial compares lansoprazole to omeprazole [abstract]. Gastroenterology 1995, 108:A67.
9. Klinkenberg-Knol EC, Festen HPM, Jansen JBMJ, Earners CBHW, Nelis F, Snel P, et al.: Long term treatment with omeprazole for refractory reflux oesophagitis: efficacy and safety. Ann Intern Med 1994 121:161-167
10. Savary M, Miller G: L'œsophage. Manuel et Atlas d'Endoscopie. Solothurn, Switzerland: Editions Gassmann SA; 1977.
11. Sekiguchi T, Horkoshi T, Nishioka T, Kusano M:. Clinical effect of proton pump inhibitors on reflux oesophagitis (in Japanese). Nippon Rinsho 1992, 50:131-137.
12. Mee AS, Rowley JL, The Lansoprazole Study Group: Lansoprazole provides greater symptom relief than omeprazole, in reflux esophagitis [abstract]. Gastroenterology 1995, 108:A164.
13. Hunt RH: The relationship between the control of pH and healing and symptom relief in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1995, 9(S1):3-7.
14. Takeda H, Hokari K, Asaka M: Evaluation of the effect of lansoprazole in suppressing acid secretion using 24-hour intragastric pH monitoring. J Clin Gastroenterol 1995, 20(S1):7-9.
15. Des Varannes SB, Levy P, Eartigue S, Dellatolas F, Lemaire M, Galmiche JP: Comparison of lansoprazole with omeprazole on 24-hour intragastric pH, acid secretion an serum gastrin in healthy volunteers. Aliment Pharmacol Ther 1994, 8:309-314
16. Meyer BH, Scholtz HE, Luus HG: Comparison of the effects of lansoprazole, omeprazole and pantoprazole on 24-hour gastric pH in healthy males [abstract]. Proceedings of The 19th Biennial Congress ASSA, 1995.
17. Tolman KG, Sanders SW, Buchi KN: Gastric pH levels after 15 mg and 30 mg lansoprazole or 20 mg omeprazole [abstract]. Proceedings of the 10th World Congress of Gastroenterology, 1994.
18. Seensalu R, Iwarzon M, Janczewska I, Hammarlund B, Oksanen A, Sagar M: Dose-response comparison of lansoprazole and omeprazole on 24-hour gastric acidity and plasma gastrin in healthy volunteers [abstract]. Gastroenterology 1995, 108(4):A215.
19. Damman HG, Richter G, Wolf N, Burkhardt F: Influence of lansoprazole 15 and 30 mg and omeprazole 20 and 40 mg on meal-stimulated gastric acid secretion (abstract). Gut 1995, 37(2):A45.
20. Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, et al.: Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988, 95:903-912.
21. Laursen LS, Bondesen S, Hansen J, Sanchez G, Sebelin E, Havelund T, et al.: Omeprazole 20 mg or 40 mg daily for the treatment of gastroesophageal reflux disease? A double blind comparative study [abstract]. Gastroenterology 1992, 102:A110.
22. Bate CM, Richardson PDI: Cost effectiveness of 20 mg and 40 mg of omeprazole in oesophageal reflux disease. Br J Med Econ 1993, 6:59-66.
23. Hendel J, Hendel L, Aggestrup S: Morning or evening dosage of omeprazole for gastro-oesophageal reflux disease? Aliment Pharmacol Ther 1995, 9:69.3-697.
24. IMS: Medical Index The Netherlands, Medical Data Index. 1993-1995.
25. Sontag SJ, Hirschowitz BI, Holt S, Robinson MG, Behar J, Berenson MM: Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: the US multicenter study. Gastroenterology 1992, 102:109-118.